Stay updated with breaking news from Mindset Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035.
As the first large pharma operation to make a significant investment in psychedelics, the rewards could be big.
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Psychedelics biotech Cybin (NYSE:CYBN) and UK-ba...
Otsuka Pharmaceutical Co. Ltd. announced plans to acquire Mindset Pharma Inc. for C$80 million (US$50.76 million) in an all-cash deal that will see Otsuka strengthen its neurology and psychiatric pipeline. Mindset, of Toronto, is developing next-generation psychedelic therapeutics to treat psychiatric and neurological disorders with high unmet needs.
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has agreed to be acquired by Otsuka Pharmaceutical Co, Ltd, through its wholly-owned Otsuka...